• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期卵巢癌上腹部手术后辅助化疗的时间间隔及术后管理

Time-interval to adjuvant chemotherapy and postoperative management after upper abdominal surgical procedures in advanced ovarian cancer.

作者信息

Joneborg Ulrika, Palsdottir Kolbrun, Farm Erik, Johansson Hemming, Salehi Sahar

机构信息

Department of Women's and Children's Health, Division of Obstetrics and Gynaecology, Karolinska Institutet, Sweden; Department of Pelvic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.

Department of Women's and Children's Health, Division of Obstetrics and Gynaecology, Karolinska Institutet, Sweden; Department of Pelvic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Eur J Surg Oncol. 2021 Feb;47(2):353-359. doi: 10.1016/j.ejso.2020.07.025. Epub 2020 Jul 31.

DOI:10.1016/j.ejso.2020.07.025
PMID:32778486
Abstract

INTRODUCTION

In advanced epithelial ovarian cancer (EOC), longer time-interval from surgery to initiation of adjuvant chemotherapy (TITC) is associated with decreased survival. Adding upper abdominal surgical procedures (UAP) increases rates of both complete gross resection and postoperative complications in EOC. Our objective was to investigate the association of UAP and TITC. Moreover, if specific postoperative monitoring after the most prevalent UAP increases early detection and management of complications.

MATERIAL AND METHODS

Women diagnosed with EOC 2014-2016 in the Stockholm/Gotland Region in Sweden were identified in the Swedish Quality Registry for Gynaecologic Cancer. The association between UAP and TITC was investigated by multivariable linear regression and adjusted for predefined confounders. The follow-up and detection of postoperative complications after diaphragm resection, splenectomy and cholecystectomy was examined.

RESULTS

240 women were selected for analysis. The TITC in women subjected to UAP was similar with a median of 30 days (p = 0.99). Moreover, despite a higher rate of postoperative and major complications (p < 0.001) and longer hospital stay (p < 0.001), in the adjusted analysis there was no association between UAP and prolonged TITC, with a mean difference of -2.27 days (95% Confidence Interval (CI), -5.99 to -1.45, p = 0.23). After the most prevalent UAP (diaphragm resection, splenectomy and cholecystectomy), eventual postoperative interventions were based on routine clinical management rather than procedure-specific postoperative surveillance.

CONCLUSION

UAP does not prolong TITC despite an increased rate of postoperative complications and longer length of hospital stay. Clinical non-specific surveillance is sufficient to detect postoperative complications after the most prevalent UAP.

摘要

引言

在晚期上皮性卵巢癌(EOC)中,从手术到开始辅助化疗的时间间隔(TITC)延长与生存率降低相关。增加上腹部手术操作(UAP)会提高EOC的完全大体切除率和术后并发症发生率。我们的目的是研究UAP与TITC之间的关联。此外,在最常见的UAP术后进行特定的术后监测是否能提高并发症的早期发现和处理。

材料与方法

在瑞典妇科癌症质量登记处中识别出2014 - 2016年在瑞典斯德哥尔摩/哥特兰地区被诊断为EOC的女性。通过多变量线性回归研究UAP与TITC之间的关联,并对预先定义的混杂因素进行调整。检查了膈切除术、脾切除术和胆囊切除术后的随访情况以及术后并发症的检测情况。

结果

选取240名女性进行分析。接受UAP的女性的TITC相似,中位数为30天(p = 0.99)。此外,尽管术后和主要并发症发生率较高(p < 0.001)且住院时间更长(p < 0.001),但在调整分析中,UAP与TITC延长之间无关联,平均差异为 -2.27天(95%置信区间(CI),-5.99至 -1.45,p = 0.23)。在最常见的UAP(膈切除术、脾切除术和胆囊切除术)之后,最终的术后干预基于常规临床管理,而非特定手术的术后监测。

结论

尽管术后并发症发生率增加且住院时间延长,但UAP并不会延长TITC。临床非特异性监测足以检测最常见UAP术后的并发症。

相似文献

1
Time-interval to adjuvant chemotherapy and postoperative management after upper abdominal surgical procedures in advanced ovarian cancer.晚期卵巢癌上腹部手术后辅助化疗的时间间隔及术后管理
Eur J Surg Oncol. 2021 Feb;47(2):353-359. doi: 10.1016/j.ejso.2020.07.025. Epub 2020 Jul 31.
2
Ultra-radical upfront surgery does not improve survival in women with advanced epithelial ovarian cancer; a natural experiment in a complete population.超根治性 upfront 手术并未改善晚期上皮性卵巢癌女性的生存;在一个完整人群中的自然实验。
Gynecol Oncol. 2020 Oct;159(1):58-65. doi: 10.1016/j.ygyno.2020.07.009. Epub 2020 Jul 22.
3
Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer.二次细胞减灭术后至辅助化疗的间隔时间与复发性卵巢癌患者的生存无关。
J Ovarian Res. 2019 Dec 31;13(1):1. doi: 10.1186/s13048-019-0602-5.
4
National trends in bowel and upper abdominal procedures in ovarian cancer surgery.卵巢癌手术中肠道和上腹部手术的全国趋势。
Int J Gynecol Cancer. 2020 Aug;30(8):1195-1202. doi: 10.1136/ijgc-2020-001243. Epub 2020 Jul 2.
5
Impact of interval from primary cytoreductive surgery to initiation of adjuvant chemotherapy in advanced epithelial ovarian cancer.原发性细胞减灭术后至辅助化疗开始时间对晚期上皮性卵巢癌的影响。
Int J Gynaecol Obstet. 2018 Dec;143(3):325-332. doi: 10.1002/ijgo.12653. Epub 2018 Sep 19.
6
Perioperative fluid balance and major postoperative complications in surgery for advanced epithelial ovarian cancer.围手术期液体平衡与晚期上皮性卵巢癌手术的主要术后并发症。
Gynecol Oncol. 2021 May;161(2):402-407. doi: 10.1016/j.ygyno.2021.02.034. Epub 2021 Mar 12.
7
Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer.在晚期卵巢癌患者中,减瘤手术和辅助化疗之间的时间间隔与总生存期相关。
Gynecol Oncol. 2018 Sep;150(3):446-450. doi: 10.1016/j.ygyno.2018.07.004. Epub 2018 Jul 9.
8
Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.新辅助化疗后延迟细胞减灭术治疗晚期上皮性卵巢癌的生存结局。
Int J Gynecol Cancer. 2020 Dec;30(12):1935-1942. doi: 10.1136/ijgc-2020-001658. Epub 2020 Oct 29.
9
Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182.晚期卵巢癌或原发性腹膜癌患者在最小或无肉眼残留肿瘤的情况下进行上腹部手术:妇科肿瘤学组(GOG)182 的分析。
Gynecol Oncol. 2013 Sep;130(3):487-92. doi: 10.1016/j.ygyno.2013.06.017. Epub 2013 Jun 17.
10
Performance validation of the Mayo triage algorithm applied to individualize surgical management of advanced epithelial ovarian cancer.梅奥分诊算法在个体化治疗晚期上皮性卵巢癌中的应用性能验证。
Gynecol Oncol. 2021 Aug;162(2):339-344. doi: 10.1016/j.ygyno.2021.06.003. Epub 2021 Jun 17.

引用本文的文献

1
Earlier is not always better: Optimal time to initiate adjuvant chemotherapy after surgery for ovarian cancer.更早并不总是更好:卵巢癌术后辅助化疗的最佳起始时间。
Arch Gynecol Obstet. 2025 Jul 11. doi: 10.1007/s00404-025-08095-3.
2
Splenectomy as a part of cytoreductive surgery in ovarian cancer: systematic review and meta-analysis.卵巢癌细胞减灭术中的脾切除术:系统评价和荟萃分析。
Int J Gynecol Cancer. 2024 Jul 1;34(7):1070-1076. doi: 10.1136/ijgc-2024-005462.
3
Incidence of and survival after surgical intervention for bowel obstruction in women with advanced ovarian cancer.
晚期卵巢癌女性并发肠梗阻的手术干预发生率和生存情况。
Acta Obstet Gynecol Scand. 2023 Dec;102(12):1653-1660. doi: 10.1111/aogs.14674. Epub 2023 Sep 8.
4
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients.原发性手术或间隔手术与辅助化疗之间的时间间隔对卵巢癌患者的影响。
Front Oncol. 2023 Aug 16;13:1221096. doi: 10.3389/fonc.2023.1221096. eCollection 2023.
5
Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study.新辅助化疗后间隔减瘤手术和术后化疗在晚期上皮性卵巢癌中的时机:一项多中心真实世界研究。
J Ovarian Res. 2023 Jun 27;16(1):121. doi: 10.1186/s13048-023-01164-8.
6
Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer.腹腔内热灌注化疗联合细胞减灭术作为晚期上皮性卵巢癌巩固治疗的作用。
Ann Surg Oncol. 2023 Jun;30(6):3287-3299. doi: 10.1245/s10434-023-13242-8. Epub 2023 Feb 23.
7
Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population-based cohort study.在初始细胞减灭术时行脾切除术治疗晚期上皮性卵巢癌的肿瘤学结局:一项全国范围内基于人群的队列研究。
Acta Obstet Gynecol Scand. 2022 Jan;101(1):56-67. doi: 10.1111/aogs.14286. Epub 2021 Nov 1.